Previous Article | Next Article 
Applied and Environmental Microbiology, December 2002, p. 6457-6461, Vol. 68, No. 12
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.12.6457-6461.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Vancomycin-Resistant Enterococci in Humans and Imported Chickens in Japan
Yoshiyuki Ozawa,1 Koichi Tanimoto,1 Takahiro Nomura,1 Masao Yoshinaga,2,3 Yoshichika Arakawa,4 and Yasuyoshi Ike1,5*
Department of Microbiology,1
Laboratory of Bacterial Drug Resistance, Gunma University School of Medicine, Maebashi, Gunma 371-8511,5
Infection Control Team, Kagoshima University Hospital,2
Department of Pediatrics, Kagoshima University School of Medicine, Sakuragaoka 8-35-1, Kagoshima 890-8520,3
Department of Bacterial and Blood Products, National Institute of Infectious Diseases, Musashi-Murayama, Tokyo 208-0011, Japan4
Received 4 March 2002/
Accepted 23 August 2002

ABSTRACT
The phenotypes and genotypes of 22 VanA-type vancomycin-resistant
enterococci that had been isolated in Japan were examined. The
VanA resistance determinant was plasmid mediated in each of
the 22 strains. Of the 22 strains, 8 were isolated from different
patients and 11 and 3 were obtained from different samples of
chickens imported from Thailand and France, respectively. Three
of the strains that were isolated from patients and the 11 strains
isolated from the Thai chickens showed high-level vancomycin
resistance (MICs, 512 to 1,024 µg/ml) and low-level teicoplanin
resistance (MICs, 0.5 to 4 µg/ml). Each of these strains
had three amino acid substitutions in the N-terminal region
of the deduced VanS sequence. L50 was converted to V, E54 was
converted to Q, and Q69 was converted to H compared to the
vanS gene sequence of Tn
1546.

INTRODUCTION
Since the first reports of infections and colonizations by vancomycin-resistant
enterococci (VRE) in France (
10) and the United Kingdom (
15),
there have been reports of VRE in many locations in the United
States and the European Union. The major factors contributing
to the dissemination of VRE in the United States and Europe
are now evident. In the United States, the major factor is likely
the excessive use of glycopeptide antibiotics in the health
care environment, resulting in a selective increase in VRE in
human intestines (
8,
11). In Europe, it is strongly suggested
that the use of avoparcin as a growth promoter in animal feed
has resulted in the selective increase in VRE in animal intestines,
and the VRE subsequently appear in the human community (
9,
13,
16,
17). In Japan, vancomycin injections have been used for
the treatment of methicillin-resistant
Staphylococcus aureus infections since November 1991 and infection or colonization
due to VRE is rare (
6,
7,
9). Until 2000, a total of eight patients
with VRE were detected in four hospitals. We have conducted
an investigation of VRE in imported and domestic chickens every
year since 1998 with the support of the Japanese Ministry of
Health, Labor, and Welfare (
9). VRE have never been isolated
from domestic chickens. However, VRE are isolated at a high
frequency in samples from imported chickens. VRE isolation frequencies
of about 20% and 30 to 50% have been observed in Thailand and
France, respectively, where avoparcin has been used in animal
feed (
9). We compared the phenotypes and genotypes of VRE isolates
from humans with those of isolates from imported chickens in
Japan.

Glycopeptide resistance and pulsed-field gel electrophoresis (PFGE) analysis of VRE strains.
Twenty-two VRE strains were examined in this study. Of these
strains, eight strains were isolated from eight different patients
at four hospitals in Japan up until 2000 and 11 and 3 strains
were obtained from chickens imported from Thailand and France,
respectively, in investigations carried out in 1998 and 1999
(Table
1).
The levels of glycopeptide resistance were examined in the VRE
strains (Table
1). Of the eight strains isolated from the patients,
five strains from patients at two hospitals showed high-level
vancomycin and teicoplanin resistance, with MICs of 256 to 512
µg/ml and 64 to 128 µg/ml, respectively, and the
other three strains from the patients at two hospitals showed
high-level vancomycin resistance, with MICs of 512 to 1,024
µg/ml, and low-level teicoplanin resistance, with MICs
of 0.5 to 4 µg/ml. Of the strains isolated from the imported
chickens, all four strains isolated from French chicken samples
showed high-level vancomycin and teicoplanin resistance, with
MICs of 512 µg/ml and 64 to 128 µg/ml, respectively.
All 11 strains isolated from Thai chicken samples showed high-level
vancomycin resistance, with MICs of 256 to 1,024 µg/ml,
and relatively low-level teicoplanin resistance, with MICs of
2 to 8 µg/ml.
The DNA from each of the VRE strains was analyzed by PCR for the presence of vancomycin resistance gene(s) with vanA-, vanB-, and vanC-specific primers (4, 5, 12). All strains gave rise to the expected 732-bp product with the primer specific for the vanA gene, indicating that the strains were VanA-type VRE (data not shown).
Banding patterns obtained by PFGE of SmaI-digested genomic DNA were used to compare the VRE strains. Figure 1 shows the PFGE patterns of VRE strains isolated from Thai chickens and VRE strains KV12, KV21, and CV1 isolated from patients, which showed high-level vancomycin resistance and low-level teicoplanin resistance, and also VRE strain FN1 (6) (Fig. 1; Table 1). Of these strains, two (KV12 and KV21) isolated from patients at a hospital and three (TV9, TV10, and TV11) isolated from Thai chickens, respectively, differed by one or two bands, indicating that strains of each group were related. Other strains showed different patterns, indicating that these VRE strains are different (Fig. 1)

Conjugative transfer of vancomycin resistance.
Each of the 22 VRE strains harbored several plasmids. The
EcoRI
restriction profiles of total plasmid DNAs isolated from the
VRE strains were different (data not shown). The v
anA probe
hybridized to a specific
EcoRI fragment (4.1 kb) of plasmid
DNA in each of the strains that is specific to the prototype
VanA-type gene encoded on Tn
1546 (
5), with the exception of
the plasmid DNAs of one strain (FV2), where the probe hybridized
to a 5-kbp
EcoRI fragment (data not shown). The transferability
of the vancomycin resistance of the VRE strains was examined
between each of the strains and recipient strain
Enterococcus faecalis FA2-2 (Rif
r Fus
r) (
3) by filter mating. The vancomycin
resistances of 5 of the 11 strains from Thai chickens and 2
of the 3 strains from the patients, which were high-level vancomycin
resistant and low-level teicoplanin resistant, and the vancomycin
resistance of one of the three strains from French chickens,
which were high-level vancomycin and teicoplanin resistant,
were transferred to the recipient
E. faecalis FA2-2 (Rif
r Fus
r)
strain at about 10
-4 to 10
-5 cells per donor cell by filter
mating (Table
1). After repeated transfer experiments done by
short mating between
E. faecalis FA2-2 (Rif
r Fus
r) and
E. faecalis JH2SS (Str
r Spc
r) (
14), the transferable plasmid from each of
the strains was identified from the transconjugant (Fig.
2).
The plasmid DNA of the transconjugants of two strains (KV12,
and KV21) isolated from patients at a hospital and three strains
(TV9, TV10, and TV11) isolated from Thai chickens, respectively,
exhibited the same
EcoRI restriction profiles (Fig.
2). The
vanA probe hybridized to a specific
EcoRI fragment (4.1 kb)
(
5) of conjugative plasmid DNA of each the transconjugants,
with the exception of the plasmid DNA isolated from strain FV2.
These results indicated that the VanA determinants, which are
encoded on transposons such as Tn
1546, are carried on a conjugative
plasmid and can transfer between enterococci and also to different
replicons by transposition.

DNA sequence analysis of the vanS gene of the vancomycin determinants encoded on the plasmids.
A nationwide survey was conducted to investigate VRE in broiler
farms in Japan in December 1996 (
18). Three VanA-type VRE strains
were isolated from droppings obtained from 3 of 35 broiler farms
in 24 prefectures in Japan that used avoparcin (
18). The three
VanA-type VRE isolates showed high-level vancomycin resistance
and relatively low-level teicoplanin resistance, and the VanA
determinant of
E. faecalis GV2, which is one of the three isolates,
was analyzed in detail (
7). The glycopeptide resistance of
E. faecalis GV2 is mediated by conjugative plasmid pMG2 (85 kb).
The nucleotide sequences of the genes for the VanA determinant
encoded on pMG2 are completely identical to those of the prototype
VanA-type gene encoded on Tn
1546, with the exception of the
gene for glycopeptide sensor protein VanS (
1). There are three
amino acid substitutions in the N-terminal region of the deduced
sequence encoded by
vanS (Table
1).
Nucleotide sequence analysis of the vanS gene of the VRE strains was performed by sequencing PCR products with vanS-specific primers (Table 2). To analyze the van determinant corresponding to vanS of the VanA-type determinant encoded on Tn1546 (2), one or two pairs of PCR primers specific for vanS were used for PCR amplifications. The pairs of PCR primers were also used to sequence the amplified genes. The nucleotide sequence and the deduced amino acid residues of the vanS gene of the VRE strains isolated from Thai chickens and from three patients at two hospitals revealed three amino acid substitutions in the N-terminal region of the deduced VanS sequence. L50 was converted to V, E54 was converted to Q, and Q69 was converted to H compared to the vanS gene sequence of Tn1546 (Table 1).
The VRE strains gave rise to the expected PCR products of 1,744,
1,856, and 926 bp with the primers specific for open reading
frame (ORF) 1, both ORFs 1 and 2, and ORF2, respectively, which
are located on Tn
1546 and encode a transposase (ORF1) and a
resolvase (ORF2) (data not shown) (
12). These results suggested
that the VanA-type determinants of VRE strains were encoded
on transposon Tn
1546 or a closely related transposon.

Concluding comments.
The VRE strains isolated from French chickens exhibited high-level
vancomycin and teicoplanin resistance and could not be distinguished
from the representative VanA-type VRE (
2,
5,
12). The VRE strains
isolated from Thai chickens exhibited high-level vancomycin
resistance and relatively low-level teicoplanin resistance,
had three amino acid substitutions in the
vanS gene of the VanA-type
determinant, and were distinguished by these characters from
the representative VanA-type VRE. The VRE strains isolated from
three patients at the two hospitals showed the same characteristics
as the VRE strains from the Thai chickens. It is very rare that
identical substitutions would occur independently in each of
the strains. Japan imports about 600,000 tons of chicken a year,
while the nation's domestic chicken production is about 1.2
million tons a year. About 100,000 tons (16.6%) of the imported
chicken come from Thailand. Although isolation of VRE is rare
in enterococci from inside or outside the health care environment,
these results imply that the VanA-type vancomycin resistance
determinant, which resides on transposons such as Tn
1546 and
can be transferred between enterococci by a conjugative plasmid,
can transfer from chickens to humans.

ACKNOWLEDGMENTS
This work was supported by grants from the Ministry of Health
Labor and Welfare and by grants from the Japanese Ministry of
Education, Science and Culture.

FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology, Gunma University School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma 371-8511, Japan. Phone: 81-27-220-7990. Fax: 81-27-220-7996. E-mail:
yasuike{at}sb.gunma-u.ac.jp.


REFERENCES
1 - Arthur, M., C. Molinas, and P. Courvalin. 1992. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 174:2582-2591.[Abstract/Free Full Text]
2 - Arthur, M., C. Molinas, F. Depardieu, and P. Courvalin. 1993. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 175:117-127.[Abstract/Free Full Text]
3 - Clewell, D. B., P. K. Tomich, M. C. Gawron-Burke, A. E. Franke, Y. Yagi, and F. Y. An. 1982. Mapping of Streptococcus faecalis plasmids pAD1 and pAD2 and studies relating to transposition of Tn917. J. Bacteriol. 152:1220-1230.[Abstract/Free Full Text]
4 - Dutka-Malen, S., S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27.[Abstract]
5 - Dutka-Malen, S., S. R. Leclercq, V. Coutant, J. Doval, and P. Courvalin. 1990. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrob. Agents Chemother. 34:1875-1879.[Abstract/Free Full Text]
6 - Fujita, N., M. Yoshimura, T. Komori, K. Tanimoto, and Y. Ike. 1998. First report of the isolation of high-level vancomycin-resistant Enterococcus faecium from a patient in Japan. Antimicrob. Agents Chemother. 42:2150.[Free Full Text]
7 - Hashimoto, Y., K. Tanimoto, Y. Ozawa, T. Murata, and Y. Ike. 2000. Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistance. FEMS Microbiol. Lett. 185:247-254.[CrossRef][Medline]
8 - Huycke, M. M., D. F. Sahm, and M. S. Gilmore. 1998. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg. Infect. Dis. 4:239-249.[Medline]
9 - Ike, Y., K. Tanimoto, Y. Ozawa, T. Nomura, S. Fujimoto, and H. Tomita. 1999. Vancomycin-resistant enterococci in imported chickens in Japan. Lancet 353:1854.[CrossRef][Medline]
10 - Leclercq, R., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161.[Medline]
11 - Martone, W. J. 1998. Spread of vancomycin resistant enterococci: why did it happen in the United States? Infect. Control Hosp. Epidemiol. 19:539-545.[Medline]
12 - Miele, A., M. Bandera, and B. P. Goldstein. 1995. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob. Agents Chemother. 39:1772-1778.[Abstract]
13 - Schouten, M. A., A. Voss, and J. A. A. Hoogkamp-Korstanje. 1997. VRE and meat. Lancet 349:1258.[Medline]
14 - Tomich, P. K., F. Y. An, and D. B. Clewell. 1980. Properties of erythromycin-inducible transposon Tn917 in Streptococcus faecalis. J. Bacteriol. 141:1366-1374.[Abstract/Free Full Text]
15 - Uttley, A. H., C. H. Collins, J. Naidoo, and R. C. George. 1988. Vancomycin-resistant enterococci. Lancet i:57-58.
16 - van den Bogaard, A. E., L. B. Jensen, and E. E. Stobberingh. 1997. Vancomycin-resistant enterococci in turkeys and farmers. N. Engl. J. Med. 337:1558-1559.[Free Full Text]
17 - Witte, W. 1998. Medical consequences of antibiotic use in agriculture. Science 279:996-997.[Free Full Text]
18 - Yoshimura, H., M. Ishimaru, Y. S. Endoh, M. Suginaka, and S. Yamatani. 1998. Isolation of glycopeptide-resistant enterococci from chickens in Japan. Antimicrob. Agents Chemother. 42:3333.[Free Full Text]
Applied and Environmental Microbiology, December 2002, p. 6457-6461, Vol. 68, No. 12
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.12.6457-6461.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Freitas, A. R., Novais, C., Ruiz-Garbajosa, P., Coque, T. M., Peixe, L.
(2009). Clonal expansion within clonal complex 2 and spread of vancomycin-resistant plasmids among different genetic lineages of Enterococcus faecalis from Portugal. J Antimicrob Chemother
63: 1104-1111
[Abstract]
[Full Text]
-
Zheng, B., Tomita, H., Inoue, T., Ike, Y.
(2009). Isolation of VanB-Type Enterococcus faecalis Strains from Nosocomial Infections: First Report of the Isolation and Identification of the Pheromone-Responsive Plasmids pMG2200, Encoding VanB-Type Vancomycin Resistance and a Bac41-Type Bacteriocin, and pMG2201, Encoding Erythromycin Resistance and Cytolysin (Hly/Bac). Antimicrob. Agents Chemother.
53: 735-747
[Abstract]
[Full Text]
-
Zheng, B., Tomita, H., Xiao, Y. H., Wang, S., Li, Y., Ike, Y.
(2007). Molecular Characterization of Vancomycin-Resistant Enterococcus faecium Isolates from Mainland China. J. Clin. Microbiol.
45: 2813-2818
[Abstract]
[Full Text]
-
Lim, S.-K., Tanimoto, K., Tomita, H., Ike, Y.
(2006). Pheromone-Responsive Conjugative Vancomycin Resistance Plasmids in Enterococcus faecalis Isolates from Humans and Chicken Feces.. Appl. Environ. Microbiol.
72: 6544-6553
[Abstract]
[Full Text]
-
Novais, C., Coque, T. M., Costa, M. J., Sousa, J. C., Baquero, F., Peixe, L. V.
(2005). High occurrence and persistence of antibiotic-resistant enterococci in poultry food samples in Portugal. J Antimicrob Chemother
56: 1139-1143
[Abstract]
[Full Text]
-
Tomita, H., Tanimoto, K., Hayakawa, S., Morinaga, K., Ezaki, K., Oshima, H., Ike, Y.
(2003). Highly Conjugative pMG1-Like Plasmids Carrying Tn1546-Like Transposons That Encode Vancomycin Resistance in Enterococcus faecium. J. Bacteriol.
185: 7024-7028
[Abstract]
[Full Text]